Consensus Revvity, Inc.

Equities

RVTY

US7140461093

Market Closed - Nyse Other stock markets 04:00:01 2024-05-21 pm EDT			5-day change	1st Jan Change
113.2 ^USD	+1.08%		+6.29%	+3.59%

May. 14	Transcript : Revvity, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:40 AM
Apr. 30	TD Cowen Adjusts Price Target on Revvity to $130 From $123	MT

Evolution of the average Target Price on Revvity, Inc.

Price target over the last 5 years

History of analyst recommendation changes

4495625a1ba19ea6e80117e925b.elYZJY0arImpsKw4YRZPzB_ayEziDjoG2n-b65d9sYw.Tj1aQ9RPwtzOxdR2KkwnoF64sS-aW09cjQ_ziNE11PUSby91wCjh692H4Q~dfa21cb6a5b590f6c6415d5cae5e338e

Analyst Recommendations on Revvity, Inc.

TD Cowen Adjusts Price Target on Revvity to $130 From $123	Apr. 30	MT
JPMorgan Adjusts Price Target on Revvity to $105 From $100, Neutral Rating Maintained	Apr. 30	MT
Baird Adjusts Price Target on Revvity to $127 From $126	Apr. 30	MT
Bernstein Adjusts Price Target on Revvity to $123 From $125, Keeps Outperform Rating	Apr. 30	MT
Nephron Adjusts Revvity's Price Target to $124 From $120	Apr. 29	MT
Bernstein Adjusts Price Target on Revvity to $125 From $126	Apr. 22	MT
Baird Adjusts Price Target on Revvity to $126 From $123	Apr. 22	MT
KeyBanc Ups Price Target on Revvity to $126 From $110, Keeps Overweight Rating	Feb. 02	MT
Raymond James Raises Price Target on Revvity to $127 From $106, Maintains Outperform Rating	Feb. 02	MT
Job data is good for the economy, not for rate cuts	Feb. 02
ANALYST RECOMMENDATIONS : Alphabet, Meta Platforms, Amazon, Wise, Clorox...	Feb. 02
BofA Securities Raises Price Target on Revvity to $117 From $104, Maintains Neutral Rating	Jan. 29	MT
Barclays Adjusts Price Target on Revvity to $105 From $92, Maintains Equal-Weight Rating	Jan. 25	MT
UBS Downgrades Revvity to Neutral From Buy, Raises Price Target to $125 From $105	Jan. 16	MT
Evercore ISI Upgrades Revvity to Outperform From In-Line, Raises Price Target to $125 From $88	Jan. 04	MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	Jan. 03
Wells Fargo Starts Revvity With Equalweight Rating, $95 Price Target	Dec. 19	MT
BofA Securities Adjusts Price Target on Revvity to $104 From $103, Maintains Neutral Rating	Dec. 12	MT
Raymond James Cuts Revvity's Price Target to $106 From $135, Maintains Outperform Rating	23-10-31	MT
UBS Adjusts Revvity Price Target to $105 From $160, Maintains Buy Rating	23-10-31	MT
Goldman Sachs Lowers Price Target on Revvity to $105 From $120, Maintains Buy Rating	23-10-31	MT
Keybanc Adjusts Price Target on Revvity to $110 From $170, Maintains Overweight Rating	23-10-31	MT
ANALYST RECOMMENDATIONS : Centene, Chevron, McDonald's, Meta, On Semiconductors...	23-10-31
Central bank bonanza!	23-10-30
Wall St rises on megacap boost ahead of Fed rate verdict	23-10-30	RE

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

113.2 USD

Average target price

123.7 USD

Spread / Average Target

+9.22%

High Price Target

162 USD

Spread / Highest target

+43.07%

Low Price Target

105 USD

Spread / Lowest Target

-7.27%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Revvity, Inc.

TD Cowen
JPMorgan Chase
Baird
Bernstein
Nephron Research
KeyBanc Capital Markets
Raymond James
BofA Securities
Barclays
UBS
Evercore ISI
Wells Fargo Securities
Goldman Sachs
Citigroup
Stifel Nicolaus
Cowen
Credit Suisse
BMO Capital
Wolfe Research

Ratings for Revvity, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar